UPDATED Apr 29, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
FER | €33.80 | -1.2% | 19.1% | €24.8b | €36.68 | PE56.4x | E16.5% | 5.1% | ||
ACS | €37.58 | -2.3% | 21.0% | €9.9b | €36.69 | PE12.6x | E3.8% | 2.4% | ||
FCC | €12.72 | -0.2% | 38.0% | €5.5b | €15.82 | PE9.4x | E2.6% | 3.9% | ||
FDR | €19.90 | -0.3% | 30.7% | €3.8b | €21.48 | PE33.2x | E23.6% | 2.8% | ||
SCYR | €3.27 | -3.3% | 10.3% | €2.3b | €3.85 | PB2.9x | E58.4% | 4.3% | ||
ENO | €20.20 | -1.7% | 71.2% | €1.8b | €26.73 | PE27.3x | E-23.1% | 2.1% | ||
CAF | €32.15 | 0.5% | 13.8% | €1.1b | €44.03 | PE12.3x | E16.5% | 3.5% | ||
TLGO | €4.42 | 0.5% | 44.0% | €547.9m | €4.71 | PE39.7x | E39.8% | 2.1% | ||
EIDF | €7.94 | -22.9% | -73.3% | €513.5m | n/a | PS1.9x | n/a | n/a | ||
GSJ | €4.07 | 0.7% | 1.8% | €264.7m | €8.78 | PE13.3x | E11.9% | 3.7% | ||
ART | €4.66 | -3.7% | 20.7% | €264.3m | €5.22 | PE22x | E28.5% | 2.3% | ||
SOL | €2.28 | 3.4% | -54.7% | €210.9m | €4.52 | PB1.4x | E43.0% | n/a | ||
OHLA | €0.34 | 2.1% | -34.0% | €202.4m | n/a | PE71.5x | E49.6% | 0% | ||
GGR | €5.70 | -2.1% | -17.4% | €169.4m | €6.73 | PE74.2x | n/a | n/a | ||
AI | €0.13 | -2.5% | 53.5% | €169.4m | n/a | PS1.6x | n/a | n/a | ||
AZK | €6.18 | -0.3% | -6.6% | €152.6m | n/a | PE8.7x | n/a | 3.0% | ||
GAM | €1.33 | 1.1% | -5.4% | €122.5m | €2.10 | PE13.8x | E22.0% | n/a | ||
MDF | €0.54 | -1.1% | -24.5% | €116.6m | n/a | PE22.5x | n/a | 0% | ||
NEA | €7.06 | 1.4% | 22.8% | €87.0m | €10.70 | PE8.1x | E8.6% | 3.8% | ||
ETC | €3.00 | -5.7% | -59.3% | €80.9m | n/a | PE36.1x | E41.7% | n/a | ||
NBI | €4.66 | 0% | -6.8% | €56.2m | €6.15 | PE49.3x | n/a | 0% | ||
CLR | €3.94 | 7.4% | 45.9% | €55.8m | n/a | PE65.1x | n/a | n/a | ||
ECG | €1.60 | 0% | 0% | €49.2m | n/a | n/a | n/a | n/a | ||
DESA | €12.30 | 0% | -13.4% | €21.9m | €18.00 | PE10.3x | E16.4% | 6.9% |